Showing 4081 - 4090 of 4173 for "Life sciences IP" with applied filters
Filters:
02 July 2018 by Managing Intellectual Property
Turkey has welcomed the new Intellectual Property Code (the IP Code) numbered 6769. This came into force on January 10 2017.
02 July 2018 by Editha Hechanova
All government agencies such as the Intellectual Property Office of the Philippines (IPOPHL) are directed to promote the use of alternative dispute resolution (ADR) in resolving disputes and cases.
02 July 2018 by Takanori Abe
Shionogi is the owner of a patent entitled Pyrimidine Derivatives (JP2648897). X filed a request for a trial for invalidation of the patent. Nippon Chemiphar intervened in the trial as a plaintiff, and AstraZeneca UK intervened in the trial in order to support the defendant.
02 July 2018 by Wayne Meiring
The Kenyan authorities have published a bill, the Statute Law (Miscellaneous Amendments) Bill 2018 (the Bill), which proposes significant changes to two pieces of IP legislation.
In a recent ruling by the Court of The Hague (ECLI:NL:RBDHA:2018:4591) a defendant/patentee has been ordered to pay the costs of nullity proceedings brought against it, despite not wishing to maintain or assert its patent.
29 June 2018 by Managing Intellectual Property
Managing Intellectual Property's list of highly recommended in-house IP counsel for 2018 revealed
04 June 2018 by Lucy Songi
For this edition of the Women in IP Interview, Lucy Songi speaks to Imogen Fowler (Hogan Lovells), Mireille Buydens (Janson Baugniet) and Ellen Shankman (Ellen B Shankman & Associates) about their experiences and what advice they would offer to up-and-coming IP practitioners
01 June 2018 by Jing He
China announced a huge government reshuffle programme. The sweeping government restructuring programme was said to be the largest reform since the end of the Mao Zedong era in the 1970s
01 June 2018 by Managing Intellectual Property
One of the two IP courts of Istanbul rejected a crucial precautionary injunction (PI) demand of a patent owner on the ground that the demand requires a full trial due to the pending invalidation action against the relevant patent.
01 June 2018 by Lily Changxin Lei
In recent years, the protection system for trade mark rights has become more and more mature in China. Non-trade mark rights have also caught the attention of IP practitioners and even outsiders.
